Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

N-acetyltransferase 2 polymorphisms, tobacco smoking, and breast cancer risk in the breast and prostate cancer cohort consortium.

Cox DG, Dostal L, Hunter DJ, Le Marchand L, Hoover R, Ziegler RG, Thun MJ; Breast and Prostate Cancer Cohort Consortium..

Am J Epidemiol. 2011 Dec 1;174(11):1316-22. doi: 10.1093/aje/kwr257. Epub 2011 Nov 10.

2.

N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white women.

Baumgartner KB, Schlierf TJ, Yang D, Doll MA, Hein DW.

Toxicol Sci. 2009 Nov;112(1):211-20. doi: 10.1093/toxsci/kfp199. Epub 2009 Aug 19.

3.

Active cigarette smoking and the risk of breast cancer at the level of N-acetyltransferase 2 (NAT2) gene polymorphisms.

Kasajova P, Holubekova V, Mendelova A, Lasabova Z, Zubor P, Kudela E, Biskupska-Bodova K, Danko J.

Tumour Biol. 2016 Jun;37(6):7929-37. doi: 10.1007/s13277-015-4685-3. Epub 2015 Dec 23.

PMID:
26700672
4.

A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer.

Hunter DJ, Hankinson SE, Hough H, Gertig DM, Garcia-Closas M, Spiegelman D, Manson JE, Colditz GA, Willett WC, Speizer FE, Kelsey K.

Carcinogenesis. 1997 Nov;18(11):2127-32.

PMID:
9395212
5.

Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis.

Ambrosone CB, Kropp S, Yang J, Yao S, Shields PG, Chang-Claude J.

Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):15-26. doi: 10.1158/1055-9965.EPI-07-0598. Epub 2008 Jan 9.

6.

N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.

Alberg AJ, Daudt A, Huang HY, Hoffman SC, Comstock GW, Helzlsouer KJ, Strickland PT, Bell DA.

Cancer Detect Prev. 2004;28(3):187-93.

PMID:
15225898
7.

Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype.

Delfino RJ, Smith C, West JG, Lin HJ, White E, Liao SY, Gim JS, Ma HL, Butler J, Anton-Culver H.

Pharmacogenetics. 2000 Jul;10(5):461-9.

PMID:
10898115
8.

N-acetyltransferase 2 polymorphism and breast cancer risk with smoking: a case control study in Japanese women.

Hara A, Taira N, Mizoo T, Nishiyama K, Nogami T, Iwamoto T, Motoki T, Shien T, Matsuoka J, Doihara H, Ishihara S, Kawai H, Kawasaki K, Ishibe Y, Ogasawara Y, Miyoshi S.

Breast Cancer. 2017 Mar;24(2):254-262. doi: 10.1007/s12282-016-0696-1. Epub 2016 Apr 11.

PMID:
27068825
9.

Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk.

Chang-Claude J, Kropp S, Jäger B, Bartsch H, Risch A.

Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):698-704.

10.

Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.

Zhou W, Liu G, Thurston SW, Xu LL, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC.

Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):15-21.

11.

Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.

Moslehi R, Chatterjee N, Church TR, Chen J, Yeager M, Weissfeld J, Hein DW, Hayes RB.

Pharmacogenomics. 2006 Sep;7(6):819-29.

PMID:
16981843
12.
13.

Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk.

Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Michalek AM, Laughlin R, Nemoto T, Gillenwater KA, Shields PG.

JAMA. 1996 Nov 13;276(18):1494-501.

PMID:
8903261
14.

Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotype.

Morabia A, Bernstein MS, Bouchardy I, Kurtz J, Morris MA.

Am J Epidemiol. 2000 Aug 1;152(3):226-32.

PMID:
10933269
15.

Pre-diagnostic smoking behaviour and poorer prognosis in a German breast cancer patient cohort - Differential effects by tumour subtype, NAT2 status, BMI and alcohol intake.

Seibold P, Vrieling A, Heinz J, Obi N, Sinn HP, Flesch-Janys D, Chang-Claude J.

Cancer Epidemiol. 2014 Aug;38(4):419-26. doi: 10.1016/j.canep.2014.05.006. Epub 2014 Jun 17.

PMID:
24950597
16.

NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.

Zhang J, Qiu LX, Wang ZH, Wang JL, He SS, Hu XC.

Breast Cancer Res Treat. 2010 Oct;123(3):877-83. doi: 10.1007/s10549-010-0807-1. Epub 2010 Feb 24.

PMID:
20180012
17.

NAT2 slow acetylator genotype as an important modifier of breast cancer risk.

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K.

Int J Cancer. 2005 Apr 20;114(4):579-84.

18.

N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women.

Deitz AC, Zheng W, Leff MA, Gross M, Wen WQ, Doll MA, Xiao GH, Folsom AR, Hein DW.

Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):905-10.

19.

Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.

Okkels H, Sigsgaard T, Wolf H, Autrup H.

Cancer Epidemiol Biomarkers Prev. 1997 Apr;6(4):225-31.

20.

Tobacco smoking, NAT2 acetylation genotype and breast cancer risk.

Lissowska J, Brinton LA, Zatonski W, Blair A, Bardin-Mikolajczak A, Peplonska B, Sherman ME, Szeszenia-Dabrowska N, Chanock S, García-Closas M.

Int J Cancer. 2006 Oct 15;119(8):1961-9.

Supplemental Content

Support Center